Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas

NCT06502171 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Neurofibromatosis 1
Plexiform Neurofibroma

Interventions

DRUG: Cabozantinib Oral Tablet
DRUG: Selumetinib Oral Capsule

Sponsor

Girish Dhall, MD

Collaborators

[object Object]
[object Object]
[object Object]